Similar articles

• Gating and blocking of calcium channels by dihydropyridines in the pancreatic B-cell.

  Malaisse-Lagae F, Mathias PC, Malaisse WJ. Malaisse-Lagae F, et al. Biochem Biophys Res Commun. 1984 Sep 28;123(3):1062-8. doi: 10.1016/s0006-291x(84)80241-7. Biochem Biophys Res Commun. 1984. PMID: 6207819
• The dihydropyridine derivative, Bay K 8644, enhances insulin secretion by isolated pancreatic islets.

  Panten U, Zielmann S, Schrader MT, Lenzen S. Panten U, et al. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jan;328(3):351-3. doi: 10.1007/BF00515566. Naunyn Schmiedebergs Arch Pharmacol. 1985. PMID: 2580242
• Stimulus-secretion coupling in beta-cells of transplantable human islets of Langerhans. Evidence for a critical role for Ca2+ entry.

  Misler S, Barnett DW, Pressel DM, Gillis KD, Scharp DW, Falke LC. Misler S, et al. Diabetes. 1992 Jun;41(6):662-70. doi: 10.2337/diab.41.6.662. Diabetes. 1992. PMID: 1375175
• Mechanisms of calcium channel modulation by beta-adrenergic agents and dihydropyridine calcium agonists.

  Tsien RW, Bean BP, Hess P, Lansman JB, Nilius B, Nowycky MC. Tsien RW, et al. J Mol Cell Cardiol. 1986 Jul;18(7):691-710. doi: 10.1016/s0022-2828(86)80941-5. J Mol Cell Cardiol. 1986. PMID: 2427730 Review.
• Activators and inactivators of Ca++ channels: new perspectives.

  Spedding M. Spedding M. J Pharmacol. 1985 Oct-Dec;16(4):319-43. J Pharmacol. 1985. PMID: 2419702 Review.